Anticancer cardamonin analogs suppress the activation of NF-kappaB pathway in lung cancer cells (Q39037388)

8 September 2017

title

Anticancer cardamonin analogs suppress the activation of NF-kappaB pathway in lung cancer cells (English)

1 reference

8 September 2017

0 references

Weiyan He

1

1 reference

8 September 2017

Yu Jiang

2

1 reference

8 September 2017

Xuebing Zhang

3

1 reference

8 September 2017

Yue Zhang

4

1 reference

8 September 2017

Honglei Ji

5

1 reference

8 September 2017

Nan Zhang

6

1 reference

8 September 2017

publication date

4 January 2014

1 reference

Molecular and Cellular Biochemistry

8 September 2017

published in

1 reference

8 September 2017

volume

389

1 reference

8 September 2017

issue

1-2

1 reference

8 September 2017

page(s)

25-33

1 reference

Population-based trends in lung cancer incidence in women

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1923-0

Drug development: portals of discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1923-0

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1923-0

Modulation of antiapoptotic cell signaling pathways in non-small cell lung cancer: the role of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1923-0

NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1923-0

Inflammation and cancer: how hot is the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1923-0

Luteolin, a flavonoid with potential for cancer prevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1923-0

Dietary agents in cancer prevention: flavonoids and isoflavonoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1923-0

Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1923-0

Transcriptional activation of survivin through the NF-kappaB pathway by human T-cell leukemia virus type I tax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1923-0

Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1923-0

Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1923-0

Proliferative inhibition, cell-cycle dysregulation, and induction of apoptosis by ursolic acid in human non-small cell lung cancer A549 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1923-0

Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1923-0

Coix seed extract, a commonly used treatment for cancer in China, inhibits NFkappaB and protein kinase C signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1923-0

Cytotoxic and inhibitory effects of 4,4'-dihydroxy chalcone (RVC-588) on proliferation of human leukemic HL-60 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1923-0

21 January 2018

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1923-0

The aromatic ketone 4'-hydroxychalcone inhibits TNFα-induced NF-κB activation via proteasome inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1923-0

Cytotoxic 2',5'-dihydroxychalcones with unexpected antiangiogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1923-0

Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3',4',5'-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1923-0

Zyflamend, a polyherbal preparation, inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of NF-kappa B activation and NF-kappa B-regulated gene products

21 January 2018

1 reference

12 December 2020

Cochinchinenin--a new chalcone dimer from the Chinese dragon blood

1 reference

12 December 2020

Chemical constituents of Cichorium intybus and their inhibitory effects against urease and alpha-chymotrypsin enzymes

1 reference

12 December 2020

Methoxychalcone induces cell-cycle arrest and apoptosis in human hormone-resistant prostate cancer cells through PI 3-kinase-independent inhibition of mTOR pathways

1 reference

12 December 2020

Growth inhibitory effects of bioflavonoids and related compounds on human leukemic CEM-C1 and CEM-C7 cells

1 reference

12 December 2020

10.1007/S11010-013-1923-0

Identifiers

DOI

1 reference

8 September 2017

1 reference